MENU
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CRISPR Therapeutics AG (CRSP) Earnings Date & Reports

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CRSP is expected to report earnings to fall 2.56% to -113 cents per share on February 17

CRISPR Therapeutics AG CRSP Stock Earnings Reports
Q4'25
Est.
$-1.14
Q3'25
Beat
by $0.09
Q2'25
Missed
by $1.00
Q1'25
Missed
by $0.37
Q4'24
Beat
by $0.79
The last earnings report on November 10 showed earnings per share of -116 cents, beating the estimate of -125 cents. With 2.92M shares outstanding, the current market capitalization sits at 4.87B.
View a ticker or compare two or three
CRSP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRSP showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com